CIK 0001314102
- Non-accelerated filer
- Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262774444
- Phone
- +1 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-21 | Lurker Nancy President & CEO | Exercise or conversion | +13,717 | 96,579 | ||
| 2021-02-21 | Lurker Nancy President & CEO | Exercise or conversion · Restricted Stock Units | −13,717 | 13,718 | ||
| 2020-09-04 | Elston George Chief Financial Officer | Purchase | +10,000 | $0.48 | $5K | 40,000 |
| 2020-08-24 | Elston George Chief Financial Officer | Purchase | +10,000 | $0.61 | $6K | 30,000 |
| 2020-06-30 | Jones David Scott SVP & Chief Commercial Officer | Exercise or conversion | +41,050 | 41,050 | ||
| 2020-06-30 | Jones David Scott SVP & Chief Commercial Officer | Shares withheld for taxes | −14,060 | $0.76 | $11K | 26,990 |
| 2020-06-30 | Jones David Scott SVP & Chief Commercial Officer | Exercise or conversion · Restricted Stock Units | −41,050 | 82,100 | ||
| 2020-06-30 | Paggiarino Dario A. Chief Medical Officer | Exercise or conversion | +41,050 | 101,193 | ||
| 2020-06-30 | Paggiarino Dario A. Chief Medical Officer | Shares withheld for taxes | −12,049 | $0.76 | $9K | 89,144 |
| 2020-06-30 | Paggiarino Dario A. Chief Medical Officer | Exercise or conversion · Restricted Stock Units | −41,050 | 82,100 | ||
| 2020-06-30 | Lurker Nancy President & CEO | Exercise or conversion | +124,667 | 784,467 | ||
| 2020-06-30 | Lurker Nancy President & CEO | Exercise or conversion · Restricted Stock Units | −124,667 | 249,333 | ||
| 2020-06-27 | Paggiarino Dario A. Chief Medical Officer | Exercise or conversion | +10,000 | 63,079 | ||
| 2020-06-27 | Paggiarino Dario A. Chief Medical Officer | Shares withheld for taxes | −2,936 | $0.79 | $2K | 60,143 |
| 2020-06-27 | Paggiarino Dario A. Chief Medical Officer | Exercise or conversion · Restricted Stock Units | −10,000 | 0 | ||
| 2020-06-27 | Lurker Nancy President & CEO | Exercise or conversion | +40,000 | 659,800 | ||
| 2020-06-27 | Lurker Nancy President & CEO | Exercise or conversion · Restricted Stock Units | −40,000 | 0 | ||
| 2020-06-14 | Lurker Nancy President & CEO | Exercise or conversion | +45,000 | 619,800 | ||
| 2020-06-14 | Lurker Nancy President & CEO | Exercise or conversion · Restricted Stock Units | −45,000 | 45,000 | ||
| 2020-06-14 | Paggiarino Dario A. Chief Medical Officer | Exercise or conversion | +14,200 | 57,247 |
Page 32 of 40 · 795 trades